Conjugated linoleic acid stimulates an anti-tumorigenic protein NAG-1 in an isomer specific manner

Carcinogenesis

Volumn 27, Issue 5, 2006, Pages 972-981

  Lee, Seong Ho ^a   Yamaguchi, Kiyoshi ^a   Kim, Jong Sik ^b   Eling, Thomas E ^c   Safe, Stephen ^d   Park, Yeonhwa ^e   Baek, Seung Joon ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

^b Andong National University   (South Korea)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^d TEXAS A AND M UNIVERSITY   (United States)

^e UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 3; CONJUGATED LINOLEIC ACID; GLYCOGEN SYNTHASE KINASE 3BETA; GROWTH FACTOR; LINOLEIC ACID; NONSTEROID ANTIINFLAMMATORY DRUG ACTIVATED PROTEIN 1; PROTEIN KINASE B; PROTEIN NAG 1; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL PROLIFERATION; CELL STRAIN HCT116; COLORECTAL CANCER; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA MICROARRAY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ACTIVATING TRANSCRIPTION FACTOR 3; ANTICARCINOGENIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; COLORECTAL NEOPLASMS; CYTOKINES; FLOW CYTOMETRY; HUMANS; LINOLEIC ACIDS, CONJUGATED; PROTEIN ISOFORMS; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 33646197169     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgi268     Document Type: Article

References (51)

1. Potter,J.D., Slattery,M.L., Bostick,R.M. and Gapstur,S.M. (1993) Colon cancer: A review of the epidemiology. Epidemiol. Rev., 15, 499-545.
2. Ha,Y.L., Grimm,N.K. and Pariza,M.W. (1987) Anticarcinogens from fried ground beef: Heat-altered derivatives of linoleic acid. Carcinogenesis, 8, 1881-1887.
3. Liew,C., Schut,H.A., Chin,S.F., Pariza,M.W. and Dashwood,R.H. (1995) Protection of conjugated linoleic acids against 2-amino-3- methylimidazo [4,5-f] quinoline-induced colon carcinogenesis in the F344 rat: A study of inhibitory mechanisms. Carcinogenesis, 16, 3037-3043.
4. MillerA., Stanton,C. and Devery,R. (2002) Cis 9, trans 11 - and trans 10, cis 12-conjugated linoleic acid isomers induce apoptosis in cultured SW480 cells. Anticancer Res., 22, 3879-3887.
5. Kim,E.J., Kang,I.J., Cho,H.J., Kim,W.K., Ha,Y.L. and Park,J.H. (2003) Conjugated linoleic acid downregulates insulin-like growth factor-I receptor levels in HT-29 human colon cancer cells. J. Nutr., 133, 2675-2681.
6. Kemp,M.Q., Jeffy,B.D. and Romagnolo,D.F. (2003) Conjugated linoleic acid inhibits cell proliferation through a p53-dependent mechanism: Effects on the expression of GI-restriction points in breast and colon cancer cells. J. Nutr., 133, 3670-3677.
7. Ealey,K.N., el-Sohemy,A. and Archer,M.C. (2001) Conjugated linoleic acid does not inhibit development of aberrant crypt foci in colons of male Sprague-Dawley rats. Nutr. Cancer, 41, 104-106.
8. Petrik,M.B., McEntee,M.F., Johnson,B.T., Obukowicz,M.G. and Whelan,J. (2000) Highly unsaturated (n-3) fatty acids, but not alpha-linolenic, conjugated linoleic or gamma-linolenic acids, reduce tumorigenesis in Apc(Min/+) mice. J. Nutr., 130, 2434-2443.
9. Baek,S.J., Kim,K.S., Nixon,J.B., Wilson,L.C. and Eling,T.E. (2001) Cyclooxygenase inhibitors regulate the expression of a TGF-beta superfamily member that has proapoptotic and antitumorigenic activities. Mol. Pharmacol., 59, 901-908.
10. Kim,K.S., Baek,S.J., Flake,G.P., Loftin,C.D., Calvo,B.F. and Eling,T.E. (2002) Expression and regulation of nonsteroidal anti-inflammatory drug-activated gene (NAG-1) in human and mouse tissue. Gastroenterology, 122, 1388-1398.
11. Liu,T., Bauskin,A.R., Zaunders,J., Brown,D.A., Pankhurst,S., Russell,P.J. and Breit,S.N. (2003) Macrophage inhibitory cytokine I reduces cell adhesion and induces apoptosis in prostate cancer cells. Cancer Res., 63, 5034-5040.
12. Baek,S.J., Wilson,L.C. and Eling,T.E. (2002) Resveratrol enhances the expression of non-steroidal anti-inflammatory drug-activated gene (NAG-1) by increasing the expression of p53. Carcinogenesis, 23, 425-434.
13. Wilson,L.C., Baek,S.J., Call,A. and Eling,T.E. (2003) Nonsteroidal antiinflammatory drug-activated gene (NAG-1) is induced by genistein through the expression of p53 in colorectal cancer cells. Int. J. Cancer, 105, 747-753.
14. Baek,S.J., Kim,J.S., Jackson,F.R., Eling,T.E., McEntee,M.F. and Lee,S.H. (2004) Epicatechin gallate-induced expression of NAG-1 is associated with growth inhibition and apoptosis in colon cancer cells. Carcinogenesis, 25, 2425-2432.
15. Lee,S.H., Kim,J.S., Yamaguchi,K., Eling,T.E. and Baek,S.J. (2005) Indole-3-carbinol and 3,3'-diindolyhnedme induce expression of NAG-1 in a p53-independent manner. Biochem. Biophys. Res. Commun., 328,63-69.
16. Baek,S.J., Yim,J.-S., NixonJ.B., DiAugustine,R.P. and Eling,T.E. (2004) Expression of NAG-1, a transforming growth factor-lbetal superfamily member, by troglitazone requires the early growth response gene EGR-1. J. Biol. Chem., 279, 6883-6892.
17. Monks,A., Harris,E., Hose,C., Connelly,J. and Sausville,E.A. (2003) Genotoxic; profiling of MCF-7 breast cancer cell line elucidates gene expression modifications underlying toxicity of the anticancer drug 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole. Mol. Pharmacol., 63, 766-772.
18. Newman,D., Sakaue,M., Koo,J.S., Kim,K.S., Baek,S.J., ElingT. and Jetten,A.M. (2003) Differential regulation of nonsteroidal anti-inflammatory drug-activated gene in normal human tracheobronchial epithelial and lung carcinoma cells by retinoids. Mol. Pharmacol., 63, 557-564.
19. Baek,S.J., Kim,J.S., Moore,S.M., Lee,S.H., Martinez,J. and Eling,T.E. (2005) Cyclooxygenase inhibitors induce the expression of the tumor suppressor gene EGR-1, which results in the up-regulation of NAG-1, an antituniorigenic protein. Mol. Pharmacol., 67, 356-364.
20. Yamaguchi,K., Lee,S.H., Eling,T.E. and Baek,S.J. (2004) Identification of nonsteroidal anti-inflammatory drug-activated gene (NAG-1) as a novel downstream target of phosphatidylinositol 3-kinase/AKT/GSK-3beta pathway. J. Biol. Chem., 279, 49617-49623.
21. Shim,M. and Eling,T.E. (2005) Protein kinase C-dependent regulation of NAG-1/placental bone morphogenic protein/MIC-1 expression in LNCaP prostate carcinoma cells. J. Biol. Chem., 280, 18636-18642.
22. Hai,T. and Hartman,M.G. (2001) The molecular biology and nomenclature of the activating transcription factor/cAMP responsive element binding family of transcription factors: Activating transcription factor proteins and homeostasis. Gene, 273, 1-11.
23. Yan,C., Jamaluddin,M.S., Aggarwal,B., Myers,J. and Boyd,D.D. (2005) Gene expression profiling identifies activating transcription factor 3 as a novel contributor to the proapoptotic effect of curcumin. Mol. Cancer Ther., 4, 233-241.
24. Yan,C., Lu,D., Hai,T. and Boyd,D.D. (2005) Activating transcription factor 3, a stress sensor, activates p53 by blocking its ubiquitination. EMBO J., 24, 2425-35.
25. Bottone,F.G. Jr, Martinez,J.M., Collins,J.B., Afshari,C.A. and Eling,T.E. (2003) Gene modulation by the cyclooxygenase inhibitor, sulindac sulfide, in human colorectal carcinoma cells: Possible link to apoptosis. J. Biol. Chem., 278, 25790-25801.
26. Iizaka,M., Furukawa,Y., Tsunoda,T., Akashi,H., Ogawa,M. and Nakamura,Y. (2002) Expression profile analysis of colon cancer cells in response to sulindac or aspirin. Biochem. Biophys. Res. Commun., 292, 498-512.
27. Castro-Rivera,E., Samudio,I. and Safe,S. (2001) Estrogen regulation of cyclin DI gene expression in ZR-75 breast cancer cells involves multiple enhancer elements. J. Biol. Chem., 276, 30853-30861.
28. Baek,S.J., Horowitz,J.M. and Eling,T.E. (2001) Molecular cloning and characterization of human nonsteroidal anti-inflammatory drug-activated gene promoter. Basal transcription is mediated by Spl and Sp3. J. Biol. Chem., 276, 33384-33392.
29. Jack,C.I., Ridgway,E., Jackson,M.J. and Hind,C.R. (1994) Serum octadeca-9,11 dienoic acid-an assay of free radical activity or a result of bacterial production? Clin. Chim. Acta, 224, 139-146.
30. Barth,A.I., Pollack,A.L., AltschulerY., Mostov,K.E. and Nelson,W.J. (1997) N112-terminal deletion of beta-catenin results in stable colocalization of mutant beta-catenin with adenomatous polyposis coli protein and altered MDCK cell adhesion. J. Cell, Biol., 136, 693-706.
31. Barth,A.I., Stewart,D.B. and Nelson,W.J. (1999) T cell factor-activated transcription is not sufficient to induce anchorage-independent growth of epithetial cells expressing mutant beta-catenin. Proc. Nod Acad. Sci. USA, 96, 4947-4952.
32. Tetsu,O. and McCormick,F. (1999) Beta-catenin regulates expression of cyclin DI in colon carcinoma cells. Nature, 398, 422-426.
33. McCarty,M.F. (2000) Activation of PPARgarnma may mediate a portion of the anticancer activity of conjugated linoleic acid. Med. Hypotheses., 55, 187-188.
34. Baek,S.J., Wilson,L.C., Hsi,L.C. and Eling,T.E. (2003) Troglitazone, a peroxisome proliferator-activated receptor gamma (PPAR gamma) ligand, selectively induces the early growth response-I gene independently of PPAR gamma. A novel mechanism for its anti-tumongemc activity. J. Biol. Chem., 278, 5845-5853.
35. ChintharlapaHi,S., Papineni,S., Baek,S.J., Liu,S. and Safe,S.H. (2005) 1,1-Bis(3′-indolyl)-I-(p-substitutedphenyl)mcthanes are peroxisome proliferator-activated receptor Igammal agomsts but decrease HCT-116 colon cancer cell survival through receptor-independent activation of early growth response-1 and NAG-1. Mol. Pharmacol., 68, 1782-1792.
36. Ip,C., Dong,Y., Ip,M.M., Banni,S., Carta,G., Angioni,E., Murru,E., Spada,S., Melis,M.P. and Saebo,A. (2002) Conjugated linoleic acid isomers and mammary cancer prevention. Nutr. Cancer, 43, 52-58.
37. Kim,E.J., Holthuizen,P.E., Park,H.S., Ha,Y.L., JungK.C. and ParkI.H. (2002) Trans- 10,cis- 12-conjugated linoleic acid inhibits Caco-2 colon cancer cell growth. Am. J. Physiol. Gastrointest. Liver Physiol., 283, G357-G367.
38. Ochoa,J.J., Farquharson,A.J., Grant,I., Moffat,L.E., Heys,S.D. and Wahle,K.W. (2004) Conjugated linoleic acids (CLAs) decrease prostate cancer cell proliferation: Different molecular mechanisms for cis-9, trans-11 and trans-10, cis-12 isomers. Carcinogenesis, 25, 1185-1191.
39. Rajakangas,J., Basu,S., Sahninen,I. and Mutanen,M. (2003) Adenoma growth stimulation by the trans-10, cis-12 isomer of conjugated linoleic acid (CLA) is associated with changes in mucosal NF-kappaB and cyclin D1 protein levels in the Min mouse. J. Nutr., 133, 1943-1948.
40. Sarraf,P., Mueller,E., Jones,D. et al. (1998) Differentiation and reversal of malignant changes in colon cancer through PPARganima. Nat. Med., 4, 1046--1052.
41. Sarraf,P., Mueller,E., Smidi,W.M., Wright,H.M., Kum,J.B., Aaltonen,L.A., de la Chapelle,A., Spiegelman,B.M. and Eng,C. (1999) Loss-of-function mutations in PPAR gamma associated with human colon cancer. Mol. Cell, 3, 799-804.
42. Lefebvre,A.M., Chen,I., Desreumaux,P., Najib,J., Fruchart,J.C., Geboes,K., Briggs,M., Heyman,R. and Auwerx,J. (1998) Activation of the peroxisome proliferator-activated receptor gamma promotes the development of colon tumors in C57BL/6J-APCMin/+ mice. Nat. Med., 4, 1053-1057.
43. Saez,E., Tontonoz,P., Nelson,M.C., Alvarez,J.G., Ming,U.T., Baird,S.M., Thomazy,V.A. and Evans,R.M. (1998) Activators of the nuclear receptor PPARgamma enhance colon polyp formation. Nat. Med., 4, 1058-1061.
44. Girnun,G.D., Smith,W.M., Drori,S. et al. (2002) APC-dependent suppression of colon carcinogenesis by PPARgamma. Proc. Natl Acad. Sci. USA, 99, 13771-13776.
45. Moya-Camarena,S.Y., Vanden Heuvel,J.P., Blanchard,S.G., Leesnitzer,L.A. and Belury,M.A. (1999) Conjugated linoleic acid is a potent naturally occurring ligand and activator of PPARalpha. J. Lipid Res., 40, 1426-1433.
46. Hashimoto,Y., Zhang,C., Kawauchij., Imoto,I., Adachi,M.T., Inazawa,J., Amagasa,T., Hai,T. and Kitajima,S. (2002) An alternatively spliced isoform of transcriptional repressor ATF3 and its induction by stress stimuli. Nucleic Acids Res., 30, 2398-2406.
47. Baek,S.J., Kim,J.S., Nixon,J.B., DiAugustine,R.P. and Eling,T.E. (2004) Expression of NAG-1, a transforming growth factor-beta superfamily member, by troglitazone requires the early growfli response gene EGR-1. J. Biol. Chem., 279, 6883-6892.
48. Vivanco,I. and Sawyers,C.L. (2002) The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat. Rev. Cancer, 2, 489-501.
49. Parsons,R. (2004) Human cancer, PTEN and the PI-3 kinase pathway. Semin, Cell Dev. Biol., 15, 171-176.
50. Beurel,E., Komprobst,M., Blivet-Van Eggelpoel,M.J., Ruiz-Ruiz,C., Cadoret,A., Capeau,J. and Desbois-Moudion,C. (2004) GSK-3beta inhibition by lithium confers resistance to chemotherapy-induced apoptosis through the repression of CD95 (Fas/APO-1) expression. Exp. Cell Res., 300, 354-364.
51. Liu,S., Yu,S., Hasegawa,Y., Lapushin,R., Xu,H.J., Woodgett,J.R., Mills,G.B. and Fang,X. (2004) Glycogen synthase kinase 3beta is a negative regulator of growth factor-induced activation of the c-Jun N-terminal kinase. J. Biol. Chem., 279, 51075-51081.